Hernemus Takuling’s life in this coastal village has changed ever since construction began on the Weda Bay Industrial Park, ...

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) ...

Shares of Valneva (VALN), a specialty vaccine company closed up over $1.00 per share or almost 19% to close the regular session at $6.67 per ...

Valneva (VALN) announced that the Medicines and Healthcare products Regulatory Agency or MHRA has granted marketing authorization in the United ...

Valneva (VALN) stock gained as its chikungunya vaccine receives marketing authorization in the U.K., expanding the single-dose shot's global reach. Read more here.

Health officials have identified a group of patients showing symptoms of Chikungunya, including children and elderly ...

Health officials have reported a rise in chikungunya cases across the country. Pediatrician at Lady Ridgeway Hospital for Ch ...

If authorised, Vimkunya would be the first vaccine in the EU to protect adolescents aged 12 to 17 against Chikungunya.

The method involves using low-dose X-rays to render male mosquitoes unable to reproduce. Male mosquitoes don't bite and won’t have contact with people or spread disease.

By altering the metabolism of the skin, the Zika virus guarantees its own survival, resulting in turning humans into mosquito ...